12th Congress of the European Crohn’s and Colitis Organisation

February 23, 2017

Biosimilar Inflectra Matches Remicade as Crohn’s Treatment, Trial Results Show

News

The biosimilar therapy Inflectra (infliximab CT-P13) is as good a treatment as Remicade (infliximab) for those with moderate-to-severe Crohn’s disease (CD), according to the results of a clinical trial. Pfizer and Celltrion Healthcare, ... Read more

February 20, 2017May 23, 2017

Janssen Reports Positive 2-Year Results for Stelara as Crohn’s Treatment

News

Janssen-Cilag International reported results from its ongoing IM-UNITI long-term extension (LTE) clinical trial assessing the efficacy and safety of subcutaneous (SC) Stelara (ustekinumab) in patients with moderate to severe Crohn’s ... Read more